195 related articles for article (PubMed ID: 37319158)
1. Effect of the interaction between atrial fibrillation and rt-PA dose on the prognosis of acute ischaemic stroke with intravenous thrombolysis.
Wu H; Liu Y; Miao G; Ge J; You S; Zhang X; Liu H; Zhou Y; Lu T; Cao Y; Shi J
Postgrad Med J; 2023 Jun; 99(1172):588-594. PubMed ID: 37319158
[TBL] [Abstract][Full Text] [Related]
2. Multimode Computed-Tomography-Guided Thrombolysis under a Prolonged Time Window in Acute Ischemic Stroke Patients with Atrial Fibrillation.
Yang Y; Sun W; Li D; Li XY; Wang XT; Li SC; Zhao HJ; Zhang JB
Int Heart J; 2019 Jul; 60(4):822-829. PubMed ID: 31257338
[TBL] [Abstract][Full Text] [Related]
3. Association of Admission Leukocyte Count with Clinical Outcomes in Acute Ischemic Stroke Patients Undergoing Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator.
Chen J; Zhang FL; Lv S; Jin H; Luo Y; Qu Y; Guo ZN; Yang Y
Curr Neurovasc Res; 2020; 17(5):660-666. PubMed ID: 33243121
[TBL] [Abstract][Full Text] [Related]
4. Nonatrial Fibrillation was Associated With Early Neurological Improvement After Intravenous Thrombolysis With rt-PA in Patients With Acute Ischemic Stroke.
Liu J; Huang J; Xu H; Dai H
Neurologist; 2020 Mar; 25(2):28-32. PubMed ID: 32132497
[TBL] [Abstract][Full Text] [Related]
5. Effect of intravenous thrombolysis in acute ischemic stroke patients with cerebral microbleeds and analysis of risk factors for hemorrhagic transformation.
Lei YS; Li H; Lei JY; Li SX; Li DF
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):779-786. PubMed ID: 35179744
[TBL] [Abstract][Full Text] [Related]
6. Baseline brain imaging signs in patients with ischaemic stroke by the presence of atrial fibrillation: the ENCHANTED trial.
Wang X; You S; Zhou Z; Delcourt C; Wardlaw J; Mair G; Robinson T; Chen X; Yoshimura S; Torii-Yoshimura T; Carcel C; Malavera A; Anderson C; Lindley RI
J Neurol; 2023 May; 270(5):2567-2575. PubMed ID: 36939933
[TBL] [Abstract][Full Text] [Related]
7. Iodinated Contrast Agents Reduce the Efficacy of Intravenous Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients: a Multicenter Cohort Study.
Chen Z; Xu C; Zhong W; Gong X; Hu H; Zhang X; Chen Y; Li Q; Luo Z; Chen Z; Lou M
Transl Stroke Res; 2021 Aug; 12(4):530-539. PubMed ID: 32895894
[TBL] [Abstract][Full Text] [Related]
8. Low-dose intravenous recombinant tissue plasminogen activator in acute ischemic stroke without large vessel occlusion screened by 3T MRI.
Huynh QS; Tran CC; Nguyen-Thi HT; Nguyen TT; Phan-Thi HL; Luu-Dang DT; Le MT; Nguyen MD
Eur Rev Med Pharmacol Sci; 2023 Jul; 27(14):6554-6562. PubMed ID: 37522667
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Different Dosages of Alteplase in Atrial Fibrillation-Related Acute Ischemic Stroke After Intravenous Thrombolysis: A Nationwide, Multicenter, Prospective Cohort Study in Taiwan.
Lin SF; Chen CF; Hu HH; Ho BL; Chen CH; Chan L; Lin HJ; Sun Y; Lin YY; Chen PL; Lin SK; Wei CY; Lin YT; Lee JT; Chao AC;
J Am Heart Assoc; 2022 Feb; 11(3):e023032. PubMed ID: 35048714
[TBL] [Abstract][Full Text] [Related]
10. Thrombolysis for acute ischaemic stroke.
Wardlaw JM; Zoppo G; Yamaguchi T; Berge E
Cochrane Database Syst Rev; 2003; (3):CD000213. PubMed ID: 12917889
[TBL] [Abstract][Full Text] [Related]
11. Relationship between chronic atrial fibrillation and worse outcomes in stroke patients after intravenous thrombolysis.
Seet RC; Zhang Y; Wijdicks EF; Rabinstein AA
Arch Neurol; 2011 Nov; 68(11):1454-8. PubMed ID: 22084129
[TBL] [Abstract][Full Text] [Related]
12. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment.
Huang Y; Sharma VK; Robinson T; Lindley RI; Chen X; Kim JS; Lavados P; Olavarría V; Arima H; Fuentes S; Nguyen HT; Lee TH; Parsons MW; Levi C; Demchuk AM; Bath PM; Broderick JP; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Pandian J; Ricci S; Stapf C; Woodward M; Wang J; Chalmers J; Anderson CS;
Int J Stroke; 2015 Jul; 10(5):778-88. PubMed ID: 25832995
[TBL] [Abstract][Full Text] [Related]
13. [Impact of atrial fibrillation on clinical outcome in patients with acute ischemic stroke undergoing thrombolytic therapy].
Lou YP; Yan SQ; Zhang S; Chen ZC; Wan JP; Lou M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 Jan; 43(1):28-35. PubMed ID: 24616458
[TBL] [Abstract][Full Text] [Related]
14. Correlation of Changes in Leukocytes Levels 24 Hours after Intravenous Thrombolysis With Prognosis in Patients With Acute Ischemic Stroke.
Chen J; Zhang Z; Chen L; Feng X; Hu W; Ge W; Li X; Jin P; Shao B
J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2857-2862. PubMed ID: 30064868
[TBL] [Abstract][Full Text] [Related]
15. Recombinant Tissue-Type Plasminogen Activator Study of Wake-Up Ischemic Strokes Guided by Rapid MRI.
Guo C; Bai Q; Zhao Z; Zhang J
Cerebrovasc Dis; 2019; 48(1-2):85-90. PubMed ID: 31587000
[TBL] [Abstract][Full Text] [Related]
16. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
[TBL] [Abstract][Full Text] [Related]
17. Increase in neutrophils after recombinant tissue plasminogen activator thrombolysis predicts poor functional outcome of ischaemic stroke: a longitudinal study.
Shi J; Peng H; You S; Liu Y; Xu J; Xu Y; Liu H; Shi R; Cao Y; Liu CF
Eur J Neurol; 2018 Apr; 25(4):687-e45. PubMed ID: 29341345
[TBL] [Abstract][Full Text] [Related]
18. Early neurological deterioration in acute ischemic stroke patients after intravenous thrombolysis with alteplase predicts poor 3-month functional prognosis - data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China).
Che F; Wang A; Ju Y; Ding Y; Duan H; Geng X; Zhao X; Wang Y
BMC Neurol; 2022 Jun; 22(1):212. PubMed ID: 35672740
[TBL] [Abstract][Full Text] [Related]
19. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
Al-Khaled M; Matthis C; Eggers J
J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915
[TBL] [Abstract][Full Text] [Related]
20. Correlation between the B-type Natriuretic Peptide before thrombolysis and prognosis in patients with ischemic stroke.
Pan H; Feng K; Fu M; Ge W; Zhou C
Clin Neurol Neurosurg; 2021 Dec; 211():107021. PubMed ID: 34808477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
